1. An Overview of Pulmonary Complications of Aids
- Author
-
Roscoe C. Young, Kathleen B. Kennedy, and Raylinda E. Rachal
- Subjects
Pharmacology ,Lung ,business.industry ,Human immunodeficiency virus (HIV) ,Pharmaceutical Science ,medicine.disease ,medicine.disease_cause ,Virology ,Antiretroviral therapy ,medicine.anatomical_structure ,Acquired immunodeficiency syndrome (AIDS) ,Immunology ,Medicine ,Pharmacology (medical) ,business - Abstract
Pulmonary complications in acquired immunodeficiency syndrome (AIDS) occur because the human immunodeficiency virus (HIV) has neutralized the cellular defenses of the lung, and in part, the mechanical and inflammatory responses as well. The consequence of this unopposed invasion, is that rare malignant tumors, opportunistic infections, as well as recognized pathogens gain entry into the reluctant host, and culminate in the host's eventual destruction. An acceptable prognosis awaits development of more effective antiretroviral therapy, as well as more efficient specific therapy for MOST of the pulmonary complications.
- Published
- 1992